Source:http://linkedlifedata.com/resource/pubmed/id/10647504
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-2-7
|
pubmed:abstractText |
The alkylating cytostatic prodrug cyclophosphamide is bioactivated by the human cytochrome P450 enzyme system. Since these enzymes are not only expressed in human liver, but also in extrahepatic tissue, local bioactivation of this drug may play an important role in its antineoplastic effects, e.g., chemotherapy of lung tumors. This would require uptake of significant amounts of cyclophosphamide into tumor tissue, which has not yet been demonstrated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0344-5704
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
63-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10647504-Aged,
pubmed-meshheading:10647504-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10647504-Biotransformation,
pubmed-meshheading:10647504-Carcinoma, Bronchogenic,
pubmed-meshheading:10647504-Cyclophosphamide,
pubmed-meshheading:10647504-Female,
pubmed-meshheading:10647504-Humans,
pubmed-meshheading:10647504-Lung,
pubmed-meshheading:10647504-Lung Neoplasms,
pubmed-meshheading:10647504-Male,
pubmed-meshheading:10647504-Middle Aged,
pubmed-meshheading:10647504-Perfusion
|
pubmed:year |
2000
|
pubmed:articleTitle |
Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation.
|
pubmed:affiliation |
Dr. Margarete Fischer-Bosch-Institut für Klinische Pharmakologie, Stuttgart, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|